This report contains market size and forecasts of Monkeypox Therapeutics in Global, including the following market information:
Global Monkeypox Therapeutics Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Monkeypox Therapeutics market was valued at US$ million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Smallpox Vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Monkeypox Therapeutics include Chimerix Inc., SIGA Technologies, Inc., Emergent BioSolutions Inc., Bavarian Nordic A/S, Hetero Drugs Limited, Mylan N.V., Piramal Enterprises Limited, Olon S.p.A. and Teva Pharmaceutical Industries Limited, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Monkeypox Therapeutics companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Monkeypox Therapeutics Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Monkeypox Therapeutics Market Segment Percentages, by Type, 2021 (%)
Smallpox Vaccine
Antivirals
Vaccinia Immune Globulin (VIG)
Global Monkeypox Therapeutics Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Monkeypox Therapeutics Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Ambulatory Surgical Centers
Others
Global Monkeypox Therapeutics Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Monkeypox Therapeutics Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Monkeypox Therapeutics revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Monkeypox Therapeutics revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Chimerix Inc.
SIGA Technologies, Inc.
Emergent BioSolutions Inc.
Bavarian Nordic A/S
Hetero Drugs Limited
Mylan N.V.
Piramal Enterprises Limited
Olon S.p.A.
Teva Pharmaceutical Industries Limited
CIDIC Company Limited
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Monkeypox Therapeutics Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Monkeypox Therapeutics Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Monkeypox Therapeutics Overall Market Size
2.1 Global Monkeypox Therapeutics Market Size: 2021 VS 2028
2.2 Global Monkeypox Therapeutics Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Monkeypox Therapeutics Players in Global Market
3.2 Top Global Monkeypox Therapeutics Companies Ranked by Revenue
3.3 Global Monkeypox Therapeutics Revenue by Companies
3.4 Top 3 and Top 5 Monkeypox Therapeutics Companies in Global Market, by Revenue in 2021
3.5 Global Companies Monkeypox Therapeutics Product Type
3.6 Tier 1, Tier 2 and Tier 3 Monkeypox Therapeutics Players in Global Market
3.6.1 List of Global Tier 1 Monkeypox Therapeutics Companies
3.6.2 List of Global Tier 2 and Tier 3 Monkeypox Therapeutics Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Monkeypox Therapeutics Market Size Markets, 2021 & 2028
4.1.2 Smallpox Vaccine
4.1.3 Antivirals
4.1.4 Vaccinia Immune Globulin (VIG)
4.2 By Type - Global Monkeypox Therapeutics Revenue & Forecasts
4.2.1 By Type - Global Monkeypox Therapeutics Revenue, 2017-2022
4.2.2 By Type - Global Monkeypox Therapeutics Revenue, 2023-2028
4.2.3 By Type - Global Monkeypox Therapeutics Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Monkeypox Therapeutics Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Specialty Clinics
5.1.4 Ambulatory Surgical Centers
5.1.5 Others
5.2 By Application - Global Monkeypox Therapeutics Revenue & Forecasts
5.2.1 By Application - Global Monkeypox Therapeutics Revenue, 2017-2022
5.2.2 By Application - Global Monkeypox Therapeutics Revenue, 2023-2028
5.2.3 By Application - Global Monkeypox Therapeutics Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Monkeypox Therapeutics Market Size, 2021 & 2028
6.2 By Region - Global Monkeypox Therapeutics Revenue & Forecasts
6.2.1 By Region - Global Monkeypox Therapeutics Revenue, 2017-2022
6.2.2 By Region - Global Monkeypox Therapeutics Revenue, 2023-2028
6.2.3 By Region - Global Monkeypox Therapeutics Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Monkeypox Therapeutics Revenue, 2017-2028
6.3.2 US Monkeypox Therapeutics Market Size, 2017-2028
6.3.3 Canada Monkeypox Therapeutics Market Size, 2017-2028
6.3.4 Mexico Monkeypox Therapeutics Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Monkeypox Therapeutics Revenue, 2017-2028
6.4.2 Germany Monkeypox Therapeutics Market Size, 2017-2028
6.4.3 France Monkeypox Therapeutics Market Size, 2017-2028
6.4.4 U.K. Monkeypox Therapeutics Market Size, 2017-2028
6.4.5 Italy Monkeypox Therapeutics Market Size, 2017-2028
6.4.6 Russia Monkeypox Therapeutics Market Size, 2017-2028
6.4.7 Nordic Countries Monkeypox Therapeutics Market Size, 2017-2028
6.4.8 Benelux Monkeypox Therapeutics Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Monkeypox Therapeutics Revenue, 2017-2028
6.5.2 China Monkeypox Therapeutics Market Size, 2017-2028
6.5.3 Japan Monkeypox Therapeutics Market Size, 2017-2028
6.5.4 South Korea Monkeypox Therapeutics Market Size, 2017-2028
6.5.5 Southeast Asia Monkeypox Therapeutics Market Size, 2017-2028
6.5.6 India Monkeypox Therapeutics Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Monkeypox Therapeutics Revenue, 2017-2028
6.6.2 Brazil Monkeypox Therapeutics Market Size, 2017-2028
6.6.3 Argentina Monkeypox Therapeutics Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Monkeypox Therapeutics Revenue, 2017-2028
6.7.2 Turkey Monkeypox Therapeutics Market Size, 2017-2028
6.7.3 Israel Monkeypox Therapeutics Market Size, 2017-2028
6.7.4 Saudi Arabia Monkeypox Therapeutics Market Size, 2017-2028
6.7.5 UAE Monkeypox Therapeutics Market Size, 2017-2028
7 Players Profiles
7.1 Chimerix Inc.
7.1.1 Chimerix Inc. Corporate Summary
7.1.2 Chimerix Inc. Business Overview
7.1.3 Chimerix Inc. Monkeypox Therapeutics Major Product Offerings
7.1.4 Chimerix Inc. Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.1.5 Chimerix Inc. Key News
7.2 SIGA Technologies, Inc.
7.2.1 SIGA Technologies, Inc. Corporate Summary
7.2.2 SIGA Technologies, Inc. Business Overview
7.2.3 SIGA Technologies, Inc. Monkeypox Therapeutics Major Product Offerings
7.2.4 SIGA Technologies, Inc. Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.2.5 SIGA Technologies, Inc. Key News
7.3 Emergent BioSolutions Inc.
7.3.1 Emergent BioSolutions Inc. Corporate Summary
7.3.2 Emergent BioSolutions Inc. Business Overview
7.3.3 Emergent BioSolutions Inc. Monkeypox Therapeutics Major Product Offerings
7.3.4 Emergent BioSolutions Inc. Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.3.5 Emergent BioSolutions Inc. Key News
7.4 Bavarian Nordic A/S
7.4.1 Bavarian Nordic A/S Corporate Summary
7.4.2 Bavarian Nordic A/S Business Overview
7.4.3 Bavarian Nordic A/S Monkeypox Therapeutics Major Product Offerings
7.4.4 Bavarian Nordic A/S Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.4.5 Bavarian Nordic A/S Key News
7.5 Hetero Drugs Limited
7.5.1 Hetero Drugs Limited Corporate Summary
7.5.2 Hetero Drugs Limited Business Overview
7.5.3 Hetero Drugs Limited Monkeypox Therapeutics Major Product Offerings
7.5.4 Hetero Drugs Limited Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.5.5 Hetero Drugs Limited Key News
7.6 Mylan N.V.
7.6.1 Mylan N.V. Corporate Summary
7.6.2 Mylan N.V. Business Overview
7.6.3 Mylan N.V. Monkeypox Therapeutics Major Product Offerings
7.6.4 Mylan N.V. Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.6.5 Mylan N.V. Key News
7.7 Piramal Enterprises Limited
7.7.1 Piramal Enterprises Limited Corporate Summary
7.7.2 Piramal Enterprises Limited Business Overview
7.7.3 Piramal Enterprises Limited Monkeypox Therapeutics Major Product Offerings
7.7.4 Piramal Enterprises Limited Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.7.5 Piramal Enterprises Limited Key News
7.8 Olon S.p.A.
7.8.1 Olon S.p.A. Corporate Summary
7.8.2 Olon S.p.A. Business Overview
7.8.3 Olon S.p.A. Monkeypox Therapeutics Major Product Offerings
7.8.4 Olon S.p.A. Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.8.5 Olon S.p.A. Key News
7.9 Teva Pharmaceutical Industries Limited
7.9.1 Teva Pharmaceutical Industries Limited Corporate Summary
7.9.2 Teva Pharmaceutical Industries Limited Business Overview
7.9.3 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Major Product Offerings
7.9.4 Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.9.5 Teva Pharmaceutical Industries Limited Key News
7.10 CIDIC Company Limited
7.10.1 CIDIC Company Limited Corporate Summary
7.10.2 CIDIC Company Limited Business Overview
7.10.3 CIDIC Company Limited Monkeypox Therapeutics Major Product Offerings
7.10.4 CIDIC Company Limited Monkeypox Therapeutics Revenue in Global Market (2017-2022)
7.10.5 CIDIC Company Limited Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Monkeypox Therapeutics Market Opportunities & Trends in Global Market
Table 2. Monkeypox Therapeutics Market Drivers in Global Market
Table 3. Monkeypox Therapeutics Market Restraints in Global Market
Table 4. Key Players of Monkeypox Therapeutics in Global Market
Table 5. Top Monkeypox Therapeutics Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Monkeypox Therapeutics Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Monkeypox Therapeutics Revenue Share by Companies, 2017-2022
Table 8. Global Companies Monkeypox Therapeutics Product Type
Table 9. List of Global Tier 1 Monkeypox Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Monkeypox Therapeutics Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Monkeypox Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Monkeypox Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Monkeypox Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Monkeypox Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Monkeypox Therapeutics Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Monkeypox Therapeutics Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Monkeypox Therapeutics Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Monkeypox Therapeutics Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Monkeypox Therapeutics Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Monkeypox Therapeutics Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Monkeypox Therapeutics Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Monkeypox Therapeutics Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Monkeypox Therapeutics Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Monkeypox Therapeutics Revenue, (US$, Mn), 2023-2028
Table 30. Chimerix Inc. Corporate Summary
Table 31. Chimerix Inc. Monkeypox Therapeutics Product Offerings
Table 32. Chimerix Inc. Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
Table 33. SIGA Technologies, Inc. Corporate Summary
Table 34. SIGA Technologies, Inc. Monkeypox Therapeutics Product Offerings
Table 35. SIGA Technologies, Inc. Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
Table 36. Emergent BioSolutions Inc. Corporate Summary
Table 37. Emergent BioSolutions Inc. Monkeypox Therapeutics Product Offerings
Table 38. Emergent BioSolutions Inc. Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
Table 39. Bavarian Nordic A/S Corporate Summary
Table 40. Bavarian Nordic A/S Monkeypox Therapeutics Product Offerings
Table 41. Bavarian Nordic A/S Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
Table 42. Hetero Drugs Limited Corporate Summary
Table 43. Hetero Drugs Limited Monkeypox Therapeutics Product Offerings
Table 44. Hetero Drugs Limited Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
Table 45. Mylan N.V. Corporate Summary
Table 46. Mylan N.V. Monkeypox Therapeutics Product Offerings
Table 47. Mylan N.V. Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
Table 48. Piramal Enterprises Limited Corporate Summary
Table 49. Piramal Enterprises Limited Monkeypox Therapeutics Product Offerings
Table 50. Piramal Enterprises Limited Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
Table 51. Olon S.p.A. Corporate Summary
Table 52. Olon S.p.A. Monkeypox Therapeutics Product Offerings
Table 53. Olon S.p.A. Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
Table 54. Teva Pharmaceutical Industries Limited Corporate Summary
Table 55. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Product Offerings
Table 56. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
Table 57. CIDIC Company Limited Corporate Summary
Table 58. CIDIC Company Limited Monkeypox Therapeutics Product Offerings
Table 59. CIDIC Company Limited Monkeypox Therapeutics Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Monkeypox Therapeutics Segment by Type in 2021
Figure 2. Monkeypox Therapeutics Segment by Application in 2021
Figure 3. Global Monkeypox Therapeutics Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Monkeypox Therapeutics Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Monkeypox Therapeutics Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Monkeypox Therapeutics Revenue in 2021
Figure 8. By Type - Global Monkeypox Therapeutics Revenue Market Share, 2017-2028
Figure 9. By Application - Global Monkeypox Therapeutics Revenue Market Share, 2017-2028
Figure 10. By Region - Global Monkeypox Therapeutics Revenue Market Share, 2017-2028
Figure 11. By Country - North America Monkeypox Therapeutics Revenue Market Share, 2017-2028
Figure 12. US Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Monkeypox Therapeutics Revenue Market Share, 2017-2028
Figure 16. Germany Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 17. France Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Monkeypox Therapeutics Revenue Market Share, 2017-2028
Figure 24. China Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 28. India Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Monkeypox Therapeutics Revenue Market Share, 2017-2028
Figure 30. Brazil Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Monkeypox Therapeutics Revenue Market Share, 2017-2028
Figure 33. Turkey Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Monkeypox Therapeutics Revenue, (US$, Mn), 2017-2028
Figure 37. Chimerix Inc. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. SIGA Technologies, Inc. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Emergent BioSolutions Inc. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Bavarian Nordic A/S Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Hetero Drugs Limited Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Mylan N.V. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Piramal Enterprises Limited Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Olon S.p.A. Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Teva Pharmaceutical Industries Limited Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CIDIC Company Limited Monkeypox Therapeutics Revenue Year Over Year Growth (US$, Mn) & (2017-2022)